GT Biopharma, Inc. Common Stock (GTBP)

Typically moves ±33.25% on earnings
EARNINGS ANALYTICS
search

GT Biopharma, Inc. Common Stock (GTBP) has only 1 recorded earnings event on file, so its post-earnings track record is limited. Its biggest recorded post-earnings gain was +33.25% (Nov 14, 2025) and its biggest decline was +33.25% (Nov 14, 2025).

Earnings reactions

How GTBP moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

1

Avg Abs. Movement

±33.25%

Positive %

100.0%

Negative %

0.0%

Historical Earnings Statistics

Date Timing Earnings move SEC Filing
Nov 14, 2025 ☀ PRE +33.25% open_in_new
event

Earnings Count

1

Total earnings in dataset

trending_up

Avg Abs. Movement

±33.25%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Mar 31, 2026 · SEC 13-F

View all 7 →
7
Funds holding
$24965
Total value held
Buying
4 added · 2 reduced
Morgan Stanley
$6774 -10.75%
Stonex Group Inc.
$6022 NEW BUY
Blackrock, Inc.
$3431 -0.01%
Citigroup Inc
$2184 NEW BUY

Frequently asked about GTBP earnings

How much does GTBP stock move after earnings? expand_more

Over 1 reports, GTBP has moved an average of ±33.25% the session after earnings, closing higher 100.0% of the time.

What was GTBP's biggest post-earnings move? expand_more

GTBP's largest post-earnings gain on record was +33.25% on Nov 14, 2025, and its largest decline was +33.25% on Nov 14, 2025.

Where can I find GT Biopharma, Inc. Common Stock's SEC filings? expand_more

All of GT Biopharma, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.